Evidence map›Paper›PMID 10882382›Full record

ArticleBritish journal of pharmacology2000

Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.

D E Selley, C C Cao, Q Liu, S R Childers

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Intracellular Transfer of NaStructure (London, England : 1993) · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Modulation of GPCRs by monovalent cations and anions.Naunyn-Schmiedeberg's archives of pharmacology · 2015
    Review
  16. Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  17. Allosteric sodium in class A GPCR signaling.Trends in biochemical sciences · 2014
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D E SelleyDepartment of Pharmacology and Toxicology and Institute for Drug and Alcohol Studies, Virginia Commonwealth University School of Medicine Box 980524, 1112 East Clay Street, Richmond, Virginia VA 23298, USA.
C C Cao
Q Liu
S R Childers
Wake Forest University · US

Funding

TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOWLETT, ALLYN C · 1991 to 2019
$30.8M
Transduction Mechanisms of Opioid Agonist EfficacyR01DA010770 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI SELLEY, DANA E · 2004 to 2007
$1.0M
MOLECULAR REGULATORY MECHANISMS OF BRAIN OPIOID SYSTEMSR01DA002904 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CHILDERS, STEVEN R · 1985 to 2002
$736k
TRANSDUCTION MECHANISMS OF OPIOID AGONIST EFFICACYR29DA010770 · NIDA · WAKE FOREST UNIVERSITY · PI SELLEY, DANA E · 1997 to 2001
$210k
NIDA NIH HHS DA02904NIDA NIH HHS DA06634NIDA NIH HHS DA10770NIDA NIH HHS P50 DA006634NIDA NIH HHS R01 DA010770NIDA NIH HHS R29 DA010770
6 · The paper itself

Abstract

1. Sodium ions inhibit spontaneous G(i)/G(o)-coupled receptor activity and promote agonist-induced responses in vitro. The effects of sodium on the relative efficacy of opioid agonists for G-protein activation was measured by guanosine-5'-O-(gamma-(35)S)-triphosphate ([(35)S]-GTPgammaS) binding in membranes from two mu-opioid receptor-containing systems: CHO cells stably transfected with mouse mureceptors (mMOR-CHO cells) and rat thalamus. 2. NaCl inhibited basal [(35)S]-GTPgammaS binding in both systems, and this effect was partially mimicked by KCl. In mMOR-CHO membranes, net [(35)S]-GTPgammaS binding stimulated by partial but not full agonists was inhibited by NaCl with a potency that was inversely proportional to agonist efficacy. Monovalent cations were required for agonist-stimulated [(35)S]-GTPgammaS binding in this system, and increasing NaCl concentrations magnified relative efficacy differences among agonists. 3. In thalamic membranes, which contain a lower receptor:G-protein ratio than mMOR-CHO cells, similar monovalent cation effects were observed, with two exceptions: (1) [(35)S]-GTPgammaS binding stimulated by both full and partial agonists was inhibited by NaCl; and (2) monovalent cations were not required to observe agonist-stimulated [(35)S]-GTPgammaS binding. 4. Basal [(35)S]-GTPgammaS binding stimulated by the absence of monovalent cations resembled that of agonist-stimulated binding and was blocked by pretreatment of mMOR-CHO cells with pertussis toxin. 5. These results indicate that sodium inhibits spontaneous and agonist-occupied mu receptor-mediated G-protein activation in a manner inversely proportional to the efficacy of the agonist, and that spontaneous mu receptor activity and the relative efficacy of partial agonists acting at these receptors are both increased by increases in the stoichiometric ratio of receptors:G-proteins.

Indexed as

AnimalsCHO CellsCricetinaeEnkephalin, Ala(2)-MePhe(4)-Gly(5)-GTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)MaleMiceMorphinePertussis ToxinRatsRats, Sprague-DawleyReceptors, Opioid, muSodium ChlorideThalamusTransfectionEnkephalin, Ala(2)-MePhe(4)-Gly(5)-GTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)MorphinePertussis ToxinReceptors, Opioid, muSodium ChlorideVirulence Factors, Bordetella

Identifiers

PMID10882382
PMCPMC1572152
OpenAlexW2058373165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.